• Explore /
  • Poster
  • / Prognostic significance of free testosterone levels during chemotherapy with carboplatin plus docetaxel (CD) in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).

Prognostic significance of free testosterone levels during chemotherapy with carboplatin plus docetaxel (CD) in metastatic castration- and docetaxel-resistant prostate cancer (mDRPC).

Abstract Poster

Authors

null

Christoph W. Reuter

Dept. Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Christoph W. Reuter , Philipp Ivanyi , Christoph A. J. von Klot , Axel Stuart Merseburger , Viktor Grünwald , Arnold Ganser

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl; abstr 5029)

DOI

10.1200/JCO.2016.34.15_suppl.5029

Abstract #

5029

Poster Bd #

286

Abstract Disclosures

Similar Posters

First Author: Christoph W. Reuter

First Author: Christoph W. Reuter

First Author: Christoph Reuter

First Author: Christoph W. Reuter